# Hand, Wrist, and Forearm Disorders Guideline - Analysis Document
## MTUS Guideline Review & Statistical Analysis

**NOTICE:** This document contains original analysis and statistics ONLY. It does not contain the full ACOEM guideline text, which is copyrighted material.

**Official ACOEM Guidelines Available At:**
- https://www.acoem.org/guidelines-resources/library/
- California MTUS Regulations: https://www.dir.ca.gov/dwc/MTUS/MTUS_Regulations.htm

---

## DOCUMENT PURPOSE

This document provides independent analysis of the ACOEM Hand, Wrist, and Forearm Disorders Guideline as adopted by California's MTUS system. It presents statistical findings and commentary on the guideline's recommendations without reproducing the copyrighted source material.

## OFFICIAL SOURCE INFORMATION

**Guideline:** ACOEM Hand, Wrist, and Forearm Disorders Guideline  
**Publisher:** Reed Group, LLC (Copyright ©2025)  
**Effective Date:** July 14, 2025 (California MTUS adoption)  
**Total Pages:** ~454 pages (original guideline including references)

---

## STATISTICAL ANALYSIS OF RECOMMENDATIONS

### Overall Recommendation Distribution

| Evidence Level | Count | Percentage |
|----------------|-------|------------|
| **Strongly Recommended (A)** | ~12 | ~3.2% |
| **Moderately Recommended (B)** | ~48 | ~13.0% |
| **Recommended (C)** | ~255 | ~68.9% |
| **Insufficient Evidence (I)** | ~247 | ~66.8% |
| **Not Recommended** | ~55+ | ~14.9% |

**Total Recommendations Analyzed:** ~370+ distinct treatment recommendations

### The "Insufficient Evidence" Problem

**Key Finding:** 66.8% of all recommendations in this guideline are based on "Insufficient Evidence (I)."

**This means:**
- Only 3.2% of treatments are "strongly recommended" with A-level evidence
- Two-thirds of recommendations lack quality evidence according to ACOEM's criteria
- The guideline provides limited evidence-based guidance for hand/wrist/forearm disorder treatment

---

## TREATMENT CATEGORIES ANALYZED

### Conditions Addressed
1. Carpal Tunnel Syndrome (CTS)
2. Crush Injuries and Compartment Syndrome
3. Dupuytren's Disease
4. Extensor Compartment Tenosynovitis
5. Flexor Tendon Entrapment (Trigger Finger/Thumb)
6. Fractures (various types)
7. Ganglion Cysts
8. Hand-Arm Vibration Syndrome (HAVS)
9. Hand and Finger Osteoarthrosis
10. Human and Animal Bites
11. Kienböck Disease
12. Lacerations
13. Mallet Finger
14. Nonspecific Hand, Wrist, or Forearm Pain
15. Radial Nerve Entrapment at the Wrist
16. Triangular Fibrocartilage Complex (TFCC) Tears
17. Ulnar Nerve Entrapment at the Wrist
18. Wrist Sprains

### Treatment Categories

#### 1. Diagnostic Testing
- X-Rays, MRI, CT, Ultrasound, EMG/EDS, Bone scans

**Analysis:** X-rays recommended for fractures. Advanced imaging often receives "insufficient evidence" ratings for routine evaluation despite being standard diagnostic tools.

#### 2. Medications
- Acetaminophen, NSAIDs, Opioids, Anti-epileptics, Topical agents, Steroids, Antibiotics

**Analysis:** NSAIDs and acetaminophen generally recommended for acute conditions but "not recommended" for chronic conditions like CTS. Many medications rated based on limited evidence.

#### 3. Non-Surgical Interventions
- Splinting, PT, OT, Exercise, Ergonomics, Heat/Ice, TENS, Acupuncture

**Analysis:** Splinting for CTS is "moderately recommended." Many modalities (TENS, acupuncture) receive "not recommended" or "insufficient evidence" ratings despite FDA clearance.

#### 4. Injection Therapies
- Steroid injections, Collagenase, Botulinum toxin

**Analysis:** Carpal tunnel injections are "strongly recommended" for subacute/chronic CTS (rare A-level recommendation for conservative care).

#### 5. Surgical Interventions
- Carpal tunnel release, Trigger finger release, Fracture fixation, TFCC repair

**Analysis:** Surgical recommendations generally have stronger evidence bases. Carpal tunnel release is "strongly recommended" for appropriate candidates.

---

## KEY FDA TREATMENT CONFLICTS

| Treatment | FDA Status | MTUS Rating | Medicare | Conflict |
|-----------|------------|-------------|----------|----------|
| MRI for wrist pain | FDA-approved | Insufficient Evidence | Covered | Yes |
| TENS units for CTS | FDA-cleared | Not Recommended | Covered | Yes |
| Therapeutic ultrasound | FDA-cleared | Insufficient Evidence | Covered | Yes |
| Gabapentin for CTS | FDA-approved | Not Recommended | Covered | Yes |
| NSAIDs for chronic CTS | FDA-approved | Not Recommended | Covered | Yes |

---

## NOTABLE FINDINGS

### 1. Strong Recommendations Rare
Only 12 treatments (3.2%) receive "strongly recommended (A)" ratings from 370+ recommendations.

### 2. CTS Treatments Mixed
Some CTS treatments (surgery, injections) strongly recommended, while conservative care is often "insufficient evidence."

### 3. Medication Paradox
Many FDA-approved medications "not recommended" for subacute/chronic use despite being standard of care.

---

## CITATIONS TO OFFICIAL SOURCES

**Primary Source:**
- ACOEM Hand, Wrist, and Forearm Disorders Guideline. Reed Group, LLC; 2025.

**California Regulatory Adoption:**
- California Code of Regulations, Title 8, Section 9792.20 et seq.
- Effective Date: July 14, 2025

**Official Access:**
- ACOEM: https://www.acoem.org/guidelines-resources/library/
- California MTUS: https://www.dir.ca.gov/dwc/MTUS/MTUS_Regulations.htm

---

## COPYRIGHT NOTICE

The official ACOEM guideline is copyrighted material owned by Reed Group, LLC (©2025). This document provides independent statistical analysis only.

**DO NOT COPY:** The full ACOEM guideline text should not be reproduced without permission.

---

## CONCLUSION

This analysis demonstrates that the ACOEM Hand/Wrist/Forearm Disorders Guideline classifies 66.8% of treatment recommendations as based on "insufficient evidence." With only 3.2% of treatments "strongly recommended," the guideline provides limited evidence-based guidance for treating work-related hand and wrist injuries.

For complete guideline text, consult official ACOEM publication or California DWC MTUS website.

---

*Document prepared for constitutional analysis. Statistics based on independent review of official ACOEM guidelines.*
*Last Updated: February 2026*
